Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Standard Dose
0.2%;EQ 0.5% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is listed in Drugs@FDA under application 219093 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BRIMONIDINE TARTRATE; TIMOLOL MALEATE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.2%;EQ 0.5% BASE Sponsor CAPLIN Submission history Latest submission status date: 2025-02-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is listed in Drugs@FDA under application 219093 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BRIMONIDINE TARTRATE; TIMOLOL MALEATE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.2%;EQ 0.5% BASE Sponsor CAPLIN Submission history Latest submission status date: 2025-02-25 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.